Evidence map›Paper›PMID 41830781›Full record

ReviewTicks and tick-borne diseases2026

Why are the ticks winning, and what can we do about it?

Lars Eisen

Abstract readReview
In one paragraph

Review in Ticks and tick-borne diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. The ecology of Lyme disease: Long-term data, surprises, and a synthesis.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Lars EisenDivision of Vector-Borne Diseases, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, 3156 Rampart Road, Fort Collins, CO 80521, United States. Electronic address: evp4@cdc.gov.

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Human illness associated with tick bites is on the rise in the United States. One root cause is that several human-biting tick species serving as pathogen vectors, including the blacklegged tick and the lone star tick, have expanded their geographic ranges in recent decades, with many areas in the U.S. now harboring multiple species of vector ticks. As currently used, personal tick bite prevention and environmental tick control have not succeeded in stemming the rising tide of humans being bitten by ticks. A national strategy to prevent and control vector-borne diseases provides a blueprint to solve the problem, but this will require sustained investments in tick bite prevention and tick control. Efforts are needed to: (i) stimulate industry engagement in development of novel technologies and products; (ii) intensify research to clarify the benefit of using different tick bite prevention and tick control methods, and clarify barriers to their adoption and use; (iii) establish publicly-funded local organizational structures to support individuals and communities in their efforts to prevent tick bites; and (iv) strengthen the workforce in public health, academia, and industry with expertise in ticks and tick-borne diseases. Solving the problem with ticks in the U.S. will be challenging but is worth pursuing because the alternative is for the public to accept that illness associated with tick bites now is simply a fact of life and that the problem is likely to get worse over time. This perspective paper includes "take home messages" and a conclusions section for an abbreviated read.

Indexed as

Arachnid VectorsTick BitesTick-Borne DiseasesTick ControlTick InfestationsTicksAnimalsHumansUnited StatesBite preventionControlTicksUnited States

Identifiers

PMID41830781
PMCPMC13036605

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.